AccuStem Sciences, Inc.
ACUT
$0.28
-$0.04-12.50%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -38.24% | -21.85% | -44.28% | 16.37% | -51.26% |
| Total Depreciation and Amortization | -100.00% | -100.00% | -88.89% | -66.67% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -90.61% | 26.06% | 66.91% | 433.52% | 1,168.84% |
| Change in Net Operating Assets | 330.81% | -351.82% | 637.27% | -80.46% | 270.63% |
| Cash from Operations | 5,500.00% | -177.24% | 110.33% | -22.24% | 100.14% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 162.25% | -100.00% | 23.53% | -100.00% |
| Total Debt Repaid | 29.63% | 3.39% | -22.58% | 54.22% | 46.53% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 29.63% | 180.96% | -110.82% | 42.76% | -113.20% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 98.44% | -88.89% | -113.62% | 358.68% | 35.35% |